Business Standard

Alembic Pharmaceuticals Share Price

Know More
BSENSE

1,172.05-17.95 (-1.51%)

02:28 PM, 11-Oct-2024

1,171.70-19.10 (-1.60%)

02:19 PM, 11-Oct-2024

BSE : 533573

NSE : APLLTD

Sector : Health care

ISIN Code : INE901L01018

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 11-Oct-2024 | 02:28 PM IST

Market Cap (₹ Cr)

23,037

Traded Value (₹ Cr)

0.62

Volume (Shares)

5,284

Face Value (₹)

2

52-Week High (₹)

1,296.15

52-Week High Date

09-Oct-2024

52-Week Low (₹)

707.50

52-Week Low Date

31-Oct-2023

All Time High (₹)

1,296.15

All Time High Date

09-Oct-2024

All Time Low (₹)

34.00

All Time Low Date

02-Jan-2012

Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world. The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business. As per the scheme of arrangement the 'Pharmaceutical Undertaking' of the Alembic Ltd was demerged and transferred to the company with effect from appointed date April 1 2010. In April 15 2011 the company ceased to be a ...
Read More

Alembic Pharma News

Alembic Pharma share price gains 5% after USFDA okays seizures drug

3 min read

What drove this pharmaceutical stock's 4% increase today? Find out here!

3 min read

Alembic Pharma shares jump 5% after USFDA approval; check details here

3 min read

Here's why Alembic Pharma stock skyrocketed 12% on August 26; details here

2 min read

Alembic Pharma gets approval from US FDA to market generic medication

1 min read

Alembic Pharma posts 11.5% growth in profit, driven by US business

2 min read
More

Alembic Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

23,030

EPS - TTM (₹) [C]

32.05

P/E Ratio (X) [C]

36.56

Face Value (₹) 2
Latest Dividend (%)550.00
Latest Dividend Date 15-Jul-2024
Dividend Yield (%) 0.92
Book Value Share (₹) [C]245.12
P/B Ratio (₹) [C]4.78

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Kotak Small Cap Fund (IDCW) 413.22 34,27,766 2.26
Kotak Small Cap Fund (G) 413.22 34,27,766 2.26
Kotak Small Cap Fund - Direct (G) 413.22 34,27,766 2.26
Kotak Small Cap Fund - Direct (IDCW) 413.22 34,27,766 2.26
AXIS Small Cap Fund (G) 174.29 14,45,780 0.70
AXIS Small Cap Fund - Direct (G) 174.29 14,45,780 0.70
Edelweiss Mid Cap Fund (G) 73.49 6,09,613 0.95
Edelweiss Mid Cap Fund (IDCW) 73.49 6,09,613 0.95
Edelweiss Mid Cap Fund - Direct (IDCW) 73.49 6,09,613 0.95
Edelweiss Mid Cap Fund - Direct (G) 73.49 6,09,613 0.95

Load more

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

1,164.00

1,204.90

Week Low/High (₹)

1,153.05

1,304.00

Month Low/High (₹)

1,110.05

1,304.00

Year Low/High (₹)

707.15

1,304.00

All time Low/High (₹)

34.00

1,304.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-5.71%-5.72%-0.40-0.26%
1 Month-6.16%-6.09%-0.200.13%
3 Month17.23%17.26%1.832.61%
6 Month18.03%17.91%8.439.65%
1 Year44.59%44.60%22.4025.94%
3 Year42.99%42.88%35.3039.03%

Company Info

Company Information

Chairman and MD & CEO : Chirayu R Amin

Independent Director : Pranav N Parikh

Independent Director : K G Ramanathan

Independent Director : Paresh Saraiya

Director & CFO : Rajkumar Baheti

Independent Director : Milin Mehta

Managing Director : Pranav Amin

Managing Director : Shaunak Amin

Independent Director : Archana Hingorani

Company Secretary : Charandeep Singh Saluja

Registered Office: Alembic Road, ,Vadodara,Gujarat-390003 Ph: 91-0265-2280550

Email:apl.investors@alembic.co.in

URL:http://www.alembic-india.com

FAQs about Alembic Pharmaceuticals Ltd

1. What's the Alembic Pharmaceuticals Ltd share price today?
Alembic Pharmaceuticals Ltd share price was Rs 1,172.05 at 02:28 PM IST on 11th Oct 2024. Alembic Pharmaceuticals Ltd share price was down by 1.51% from the previous closing price of Rs 1,190.00. Alembic Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Alembic Pharmaceuticals Ltd share price moved down by 6.16% on BSE
  • Last 3 Months: Alembic Pharmaceuticals Ltd share price moved up by 17.23% on BSE
  • Last 12 Months: Alembic Pharmaceuticals Ltd share price moved up by 44.59% on BSE
  • Last 3 Years: Alembic Pharmaceuticals Ltd price moved up by 42.99% on BSE


2. How can I quickly analyse the performance of the Alembic Pharmaceuticals Ltd stock?
The performance of the Alembic Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 36.56
  • Price to book value ratio is 4.78
  • Dividend yield of 0.92
  • The EPS (trailing 12 months) of the Alembic Pharmaceuticals Ltd stock is Rs 32.05


3. What is the market cap of Alembic Pharmaceuticals Ltd?
Alembic Pharmaceuticals Ltd has a market capitalisation of Rs 23,037 crore.


4. What is Alembic Pharmaceuticals Ltd's 52-week high/low share price?
The Alembic Pharmaceuticals Ltd’s 52-week high share price is Rs 1,296.15 and 52-week low share price is Rs 707.50.


5. Is the Alembic Pharmaceuticals Ltd profitable?
On a consolidated basis, Alembic Pharmaceuticals Ltd reported a profit of Rs 176.19 crore on a total income of Rs 1,478.71 crore for the quarter ended 2024. For the year ended Jun 2024, Alembic Pharmaceuticals Ltd had posted a profit of Rs 134.54 crore on a total income of Rs 1,564.15 crore.


6. Which are Alembic Pharmaceuticals Ltd’s peers in the Health care sector?
Alembic Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Pfizer, Natco Pharma, Laurus Labs, Alembic Pharma, Concord Biotech, Astrazeneca Phar, ERIS Lifescience.


7. Who owns how much in Alembic Pharmaceuticals Ltd?
Key changes to the Alembic Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Alembic Pharmaceuticals Ltd has gone up to 69.61 per cent as of Jun 2024 from 69.61 per cent as of Sep 2023.